吡格列酮联合二甲双胍对初诊2型糖尿病患者血清脂联素的影响

吡格列酮联合二甲双胍对初诊2型糖尿病患者血清脂联素的
影响
魏文华;林耘如
【期刊名称】《实用医技杂志》
【年(卷),期】2014(000)012
【摘要】目的：探讨吡格列酮联合二甲双胍对初诊2型糖尿病患者血清脂联素（APN）水平的影响。

方法对我院初诊60例2型糖尿病患者依治疗用药情况分为治疗组30例及对照组30例。

治疗组予吡格列酮联合二甲双胍治疗，对照组予二甲双胍治疗，疗程均为12周。

观察2组患者治疗前后的血清APN、空腹血糖（FBG）、糖化血红蛋白（HbA1c）、胰岛素抵抗（IR）水平、血脂的变化。

结果与治疗前相比，治疗组APN水平明显升高（P＜0.05），FPG、HbA1c、HOMA-IR、空腹胰岛素（FIns）明显降低（P<0.05），血脂代谢得到改善；与治疗前相比，对照组 APN水平没有明显改变，FPG、HbA1c、HOMA-IR、FIns明显降低（P<0.05）；治疗组 FPG、HbA1c、HOMA-IR及对脂代谢的改善效果优于对照组。

结论采用吡格列酮联合二甲双胍治疗，可提高2型糖尿病患者血清APN水平，进一步改善患者的IR状态。

%Objective To investigate pioglitazone combined with metformin in type 2 diabetes mellitus effects on serum levels of adiponectin (APN). Methods Sixty cases of poor application of our hospital sulfonylurea therapy glycemic control in type 2 diabetes patients were randomly divided into a treatment group of 30 patients and a control group of 30 patients. Treatment group to pioglitazone metformin therapy, the control group was given metformin, a
course of 12 weeks. Serum APN were observed before and after treatment, fasting blood glucose (FBG), glycated hemoglobin (HbA1c), insulin resistance (IR), changes in blood lipids. Results Compared with before treatment, the treatment group APN levels were significantly
increased(P<0.05), the treatment group FPG, HbA1c, HOMA-IR, FIns significantly lower(P<0.05), lipid metabolism was improved;compared with before treatment, APN levels of the control group did not change significantly, FPG, HbA1c, HOMA-IR, FIns, significantly lower (P<0.05); treatment group FPG, HbA1c, HOMA-IR effects on lipid metabolism and improvement than the control group. Conclusion For poor sulfonylurea therapy in type 2 diabetes patients with pioglitazone metformin therapy can improve type 2 serum APN levels in patients with diabetes, insulin resistance and further improve the patient′s condition.
【总页数】3页(P1269-1271)
【作者】魏文华;林耘如
【作者单位】广东省汕头市金平区人民医院 515041;广东省汕头市金平区人民医院 515041
【正文语种】中文
【相关文献】
1.吡格列酮联合二甲双胍对初诊2型糖尿病患者血清视黄醇结合蛋白4水平的影响[J], 陈红梅;李洪彬;邱谷;戴士荣;汤永新
2.吡格列酮联合二甲双胍治疗对老年2型糖尿病患者HbA1c、血脂及胰岛素敏感
性的影响 [J], 郭珍;蔡卫平;杜亚平
3.胰岛素联合罗格列酮或二甲双胍随机对照治疗对2型糖尿病患者血清脂联素的影响 [J], 胡茂清;田浩明;张俭;吴文莉;周贤会;赵万燕
4.二甲双胍分别联合西格列汀及吡格列酮对2型糖尿病患者血糖、胰岛β细胞功能和胰岛素抵抗的影响 [J], 黄春梅
5.胰岛素与格列美脲分别联合二甲双胍对2型糖尿病患者血清脂联素及糖化血红蛋白水平的影响 [J], 张素英;赵益增;吴建章;陈永平
因版权原因，仅展示原文概要，查看原文内容请购买。